Kupando: Funding, Investors & Team (Oct 2026)
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity. The company's mission is to provide cancer patients with not only safe but also inexpensive immunotherapy, as well as to produce immunostimulatory drugs capable of preventing infectious illnesses.
Kupando has raised $11.5M across 1 funding round on record, the most recent a Series A of $11.5M announced in Mar 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kupando Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Kupando Funding Rounds
Kupando Founders and Leadership Team
Contact details for the Kupando team: 1 has a LinkedIn profile.
Start 14-day free trial →Kupando Funding Compared to Other Biotechnology Startups
Kupando's latest round of $11.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kupando in Biotechnology and Schönefeld
Companies Similar to Kupando
Artcline is a biotech company that creates diagnostic and therapeutic techniques for critical care medicine.
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
Kupando Funding FAQs
What does Kupando do?
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity. The company's mission is to provide cancer patients with not only safe but also inexpensive immunotherapy, as well as to produce immunostimulatory drugs capable of preventing infectious illnesses.
How much funding has Kupando raised?
Kupando has raised $11.5M across 1 round on record. The most recent is a Series A of $11.5M announced in Mar 2026.
When did Kupando last raise funding?
Kupando's most recent funding round on record is a Series A of $11.5M, announced in Mar 2026.
Who founded Kupando?
FundedIQ lists Jorn Aldag Kupando Gmbh (Founder) at Kupando.
Where is Kupando headquartered?
Kupando is based in Schönefeld, Brandenburg, Germany.
How many employees does Kupando have?
Kupando is in the 11-50 employee band.
How does Kupando's funding compare to other Biotechnology startups?
Kupando's latest round of $11.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Kupando Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kupando is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.